Taiyen Biotech Co. Ltd.(TW:1737)
NT$29.75-0.15 (-0.50%)
TW:1737
Taiyen Biotech Co. Ltd. financials statements
NT$29.75
At close:-0.15 (-0.50%)
Taiyen Biotech Co. Ltd. (1737) Income Statement
Taiyen Biotech Co. Ltd. Income Statement
Last quarter (Q2 2026), Taiyen Biotech Co. Ltd.'s total revenue was NT$769.01M, a decrease of 10.29% from the same quarter last year. In Q2, Taiyen Biotech Co. Ltd.'s net income was NT$79.62M. See Taiyen Biotech Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 3.31B | NT$ 3.24B | NT$ 3.41B | NT$ 3.61B | NT$ 4.10B | |
| NT$ 1.34B | NT$ 1.32B | NT$ 1.21B | NT$ 1.28B | NT$ 1.37B | |
| NT$ 866.87M | NT$ 890.10M | NT$ 897.05M | NT$ 831.55M | NT$ 844.06M | |
| Depreciation and Amortization | NT$ 245.92M | NT$ 218.59M | NT$ 198.06M | NT$ 194.95M | NT$ 189.66M |
| NT$ 720.11M | NT$ 657.96M | NT$ 530.52M | NT$ 640.00M | NT$ 718.84M | |
| NT$ 476.14M | NT$ 430.81M | NT$ 312.66M | NT$ 535.11M | NT$ 515.86M | |
| NT$ 17.83M | NT$ 2.22M | NT$ 16.46M | NT$ -4.52M | NT$ -19.26M | |
| NT$ 493.97M | NT$ 433.03M | NT$ 329.12M | NT$ 530.59M | NT$ 509.92M | |
| NT$ 399.87M | NT$ 371.52M | NT$ 300.39M | NT$ 426.70M | NT$ 393.23M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.00 | NT$ 1.86 | NT$ 1.50 | NT$ 2.13 | NT$ 1.97 |
| Diluted EPS | NT$ 2.00 | NT$ 1.85 | NT$ 1.50 | NT$ 2.13 | NT$ 1.96 |
| Weighted Average Shares Outstanding | 196.84M | 200.00M | 200.26M | 200.00M | 200.00M |
| Weighted Average Shares Outstanding (Diluted) | 196.84M | 200.59M | 200.48M | 200.64M | 200.57M |
Currency in TWD
